One in Three Eligible for Bowel Cancer Screening in England Fail to Complete Test, Warns Bowel Cancer UK as Preventable Deaths Loom

Nearly a third of people eligible for bowel cancer screening in England are failing to complete the test, according to a stark warning from Bowel Cancer UK. The charity's analysis of NHS data reveals that just 71% of adults aged 50 to 74 have returned their faecal immunochemical test (FIT) kits, leaving 29% of those at highest risk untested. This gap in participation, the charity argues, could lead to thousands of preventable deaths as cancers are detected at later, less treatable stages. The issue has sparked urgent calls for action, particularly in regions where uptake falls far below the national average.

The FIT test, introduced in 2019 as part of a nationwide NHS initiative, is designed to detect microscopic traces of blood in stool samples—a potential early indicator of bowel cancer. The process is simple: individuals receive a home testing kit by post, complete the test, and return it for analysis. Results are typically available within two weeks. If no blood is detected, no further action is required, and the test is repeated every two years. However, a positive result triggers a referral for a colonoscopy, a critical step in diagnosing the disease at an early, more treatable stage. Despite the simplicity of the test, the charity's findings highlight a persistent challenge in engaging the public.

NHS Devon Integrated Care Board (ICB) reported the highest participation rate at 76%, slightly above the national average. In contrast, NHS North West London ICB recorded the lowest uptake at just 56%, a figure that has alarmed health officials. All ICBs across Greater London fell below the national average, raising concerns about regional disparities in healthcare engagement. Genevieve Edwards, chief executive of Bowel Cancer UK, emphasized the urgency of the situation: "These figures show there's still room to improve screening uptake even further. Bowel cancer is the UK's fourth most common cancer, but screening is one of the best ways to spot the disease early or remove polyps that might develop into cancer."

Screening for bowel cancer was first introduced in England in 2006, with the FIT test replacing the older guaiac-based faecal occult blood test (gFOBt) due to its superior accuracy in detecting blood. The transition was intended to increase early diagnosis rates and reduce mortality. However, the charity's analysis underscores the need for continued efforts to boost participation. With around 17,700 people dying from bowel cancer annually in the UK—making it the second biggest cancer killer—the stakes are high. Early detection remains a critical factor in improving survival rates, with over nine in 10 people surviving the disease when diagnosed at the earliest stage.

The NHS has outlined key symptoms that may indicate bowel cancer, including persistent changes in bowel habits such as unexplained diarrhoea, looser stools, or constipation, as well as blood in the stool or rectal bleeding. Other warning signs include stomach pain, a lump in the abdomen, unexplained weight loss, bloating, and fatigue or shortness of breath, which may signal anaemia linked to the disease. Risk factors are well-documented: age over 50, smoking, obesity, and a diet low in fibre or high in red and processed meats all contribute to increased risk.

Experts stress that lifestyle modifications can significantly reduce the risk of developing bowel cancer. A diet rich in fibre—such as fruits, vegetables, and wholegrains—combined with regular physical activity, reduced alcohol consumption, smoking cessation, and limiting red and processed meats, can help protect the bowel. These measures reduce inflammation, improve gut function, and minimize exposure to carcinogenic compounds. Bowel Cancer UK and the NHS continue to urge eligible individuals to complete their screening tests, emphasizing that early detection remains the most effective tool in the fight against this deadly disease.